Ghrelin Dosage: How Much to Take, When & How

Ghrelin Dosage: How Much to Take, When & How

Overview

Ghrelin is a 28-amino acid peptide hormone known as the "hunger hormone" due to its potent appetite-stimulating effects. It works by binding to growth hormone secretagogue receptors (GHSR-1a) in the hypothalamus and pituitary, triggering increased appetite, promoting growth hormone secretion, and modulating energy homeostasis. While ghrelin remains investigational and is not FDA or EMA-approved for therapeutic use, it is administered via injection in research and clinical contexts for appetite stimulation, metabolic support, and recovery enhancement.

This guide provides practical dosing information based on current research and clinical investigation protocols. Important disclaimer: This is educational content only and not medical advice. Ghrelin is not approved for human use and remains investigational. Consult a qualified healthcare provider before considering any peptide protocol.

Standard Dosing Protocol

The established dosing range for ghrelin is 1–3 mcg/kg administered once to twice daily via injection.

Baseline calculation:

• Multiply your body weight in kilograms by 1–3 mcg
• A 80 kg individual would use 80–240 mcg per dose
• A 70 kg individual would use 70–210 mcg per dose

Frequency options:

• Once daily: typically administered in the morning to stimulate appetite for the day
• Twice daily: morning and evening, spaced 8–12 hours apart for sustained appetite modulation

Most clinical investigations use once-daily dosing, particularly for appetite stimulation in cachexia, anorexia nervosa, and gastroparesis protocols. Twice-daily dosing may be employed in more intensive recovery or metabolic support contexts, though research on split dosing remains limited.

Dosing by Goal

Ghrelin's primary efficacy is appetite stimulation and growth hormone promotion. Dosing may be adjusted based on intended outcomes, though evidence for specific dose-response relationships in humans is limited.

For appetite stimulation and weight gain:

• Dose: 1–2 mcg/kg once daily
• Timing: 30–60 minutes before meals to maximize food intake
• Onset: Transient hunger and increased food intake occur within 30–60 minutes of administration
• Duration: Effects typically last 2–4 hours

For growth hormone stimulation and metabolic support:

• Dose: 2–3 mcg/kg once daily
• Timing: Morning administration is preferred for alignment with natural GH secretion patterns
• Note: Growth hormone elevation is independent of GHRH and occurs via calcium-mediated signaling at GHSR-1a receptors

For injury recovery and tissue repair:

• Dose: 1–2 mcg/kg once to twice daily
• Timing: Consistent administration maintains elevated ghrelin exposure; animal models of colonic anastomosis repair used 10 ng/kg/day
• Expected timeline: Animal studies show significant improvements in wound healing and tissue integrity within 7–14 days; human data are limited

For appetite restoration in cachexia or anorexia nervosa:

• Dose: 1–3 mcg/kg once to twice daily (upper range more common in clinical trials)
• Timing: Twice-daily dosing may provide sustained appetite stimulus
• Note: Clinical benefit is appetite-driven; weight gain depends on adequate caloric intake

How to Administer

Ghrelin is administered exclusively via subcutaneous or intramuscular injection.

Preparation:

• Ghrelin is supplied as a lyophilized (freeze-dried) powder and must be reconstituted with bacteriostatic water or saline
• Follow reconstitution instructions provided by the supplier carefully
• Common reconstitution volumes range from 1–2 mL to achieve concentrations of 100–500 mcg/mL
• Store reconstituted ghrelin in a refrigerator (2–8°C) and use within 2–4 weeks to maintain stability

Injection technique:

• Subcutaneous (SC): Most common route for research and self-administration. Inject into fatty tissue on the abdomen, outer thigh, or upper arm at a 45–90-degree angle using a 27–30 gauge insulin needle.
• Intramuscular (IM): Less commonly used; may be employed in clinical settings for faster absorption if needed.
• Rotate injection sites daily to minimize localized irritation and lipohypertrophy (fatty lump formation)

Dosing example:

• 80 kg individual, target dose 2 mcg/kg = 160 mcg per injection
• Reconstituted vial at 200 mcg/mL concentration = 0.8 mL per injection
• Use an insulin syringe for precise measurement

Side effects at injection site:

• Flushing and warmth sensations are common and typically transient
• Mild inflammation or redness may occur; rotate sites to prevent buildup
• Nausea or gastrointestinal discomfort may occur, particularly at higher doses

Cycling & Timing

Research on optimal cycling protocols for ghrelin is limited due to its investigational status. However, practical cycling strategies based on mechanistic understanding and clinical trial designs are available.

Continuous dosing:

• Most clinical trials employ continuous daily administration
• Typical trial durations range from 2–12 weeks
• Long-term safety data are limited; continuous use beyond 12 weeks should be approached cautiously

Cycling strategy (if employing breaks):

• 4–8 weeks on, 1–2 weeks off is a conservative approach to prevent receptor downregulation
• Ghrelin receptor (GHSR-1a) sensitivity may diminish with prolonged continuous exposure
• Periodic breaks allow receptor sensitivity to recover

Timing within the day:

• Morning (6–8 AM): Aligns with natural diurnal ghrelin rhythm and stimulates appetite throughout the day; preferred for once-daily dosing
• Before meals: Administer 30–60 minutes before intended meals to maximize appetite stimulation and food intake
• Evening dose (if twice daily): Administer 4–6 PM to avoid disrupting nighttime glucose regulation or sleep

Pre/post-meal administration:

• Ghrelin is most effective when administered on an empty or semi-empty stomach
• Fasted state enhances appetite-stimulating effects
• Taking ghrelin immediately after a large meal reduces efficacy

Circadian considerations:

• Ghrelin naturally peaks in the early morning and before meals
• Aligning administration with natural circadian patterns may enhance physiological responsiveness
• Evening administration may increase hunger signals and affect sleep quality in sensitive individuals

Beginner vs Advanced Dosing

Beginner protocol (first 4 weeks):

• Start at the lower end: 1 mcg/kg once daily
• For an 80 kg individual: 80 mcg once daily in the morning
• Assess tolerance for hunger sensation, nausea, and injection site reactions
• Once-daily dosing is simpler and allows for assessment of individual response
• Expected cost: $80–$150/month depending on supplier and body weight

Intermediate protocol (weeks 4–12):

• Increase to 1.5–2 mcg/kg once daily if tolerance is established and goals are not met
• For an 80 kg individual: 120–160 mcg once daily
• Consider adding an evening dose (0.5–1 mcg/kg) if appetite stimulation is insufficient
• Expected cost: $150–$250/month

Advanced protocol (beyond 12 weeks, if continuing):

• Employ 2–3 mcg/kg split dosing: 1.5 mcg/kg in the morning, 0.5–1.5 mcg/kg in the evening
• For an 80 kg individual: 120 mcg AM, 40–120 mcg PM
• Consider periodic cycling (4–8 weeks on, 1–2 weeks off) to maintain receptor sensitivity
• Monitor growth hormone, insulin, cortisol, and prolactin levels every 8–12 weeks if available
• Expected cost: $250–$400/month

Progression guidance:

• Increase dose by 0.5 mcg/kg increments every 2–4 weeks
• Allow at least 2 weeks at each dose level to assess full effects
• Do not increase if experiencing significant nausea, blood glucose fluctuations, or other adverse effects

Common Dosing Mistakes

1. Exceeding 3 mcg/kg per dose

• Doses above 3 mcg/kg lack human clinical support and increase risk of side effects
• Nausea and gastrointestinal discomfort escalate significantly at higher doses
• No evidence suggests supraphysiological doses enhance efficacy

2. Administering without reconstitution or using degraded peptide

• Ghrelin is a peptide and degrades over time, especially if improperly stored
• Always verify reconstitution instructions and storage protocols
• Use reconstituted peptide within 2–4 weeks; discard if discolored or cloudy

3. Dosing immediately after meals

• Ghrelin is a fasting hormone; post-meal administration reduces effectiveness
• Administer on an empty or semi-empty stomach for maximal appetite-stimulating effect
• Wait 2–3 hours after a large meal before injection

4. Ignoring site rotation

• Repeated injections in the same site cause lipohypertrophy (fatty deposits)
• Rotate injection sites daily: abdomen, thighs, arms
• Lipohypertrophy may reduce absorption and increase injection pain

5. Failing to account for body weight changes

• Dosing is weight-based; recalculate dose if significant weight loss or gain occurs
• A 10 kg weight change alters absolute dose by 10–30 mcg, which may meaningfully affect efficacy

6. Continuous dosing without assessment

• Long-term safety data are limited; continuous use beyond 12 weeks is investigational
• Monitor for receptor desensitization: if appetite stimulation diminishes over time, consider cycling
• Assess cortisol and prolactin elevation; transient increases are expected but warrant monitoring

7. Mixing injection routes without reason

• Stick with subcutaneous (SC) for consistent, predictable absorption
• Intramuscular (IM) absorption is faster but less suitable for daily self-administration
• Do not alternate between routes; consistency improves predictability

8. Administering without considering fasting state

• Ghrelin efficacy depends on baseline insulin and glucose levels
• Administer in a fasting or semi-fasted state (2–3 hours post-meal minimum)
• If blood glucose control is impaired, morning fasting administration is preferred

Summary Dosing Table

Final Dosing Principles

Ghrelin dosing is weight-based and simple in execution but requires attention to timing, storage, and injection technique. The effective range of 1–3 mcg/kg covers most research and clinical applications. Beginners should start low (1 mcg/kg once daily) and titrate upward based on appetite response and side effect tolerance. Intermediate users benefit from split dosing or increased once-daily doses (1.5–2 mcg/kg). Advanced users may employ the full 2–3 mcg/kg range, consider cycling protocols, and monitor endocrine markers.

Key reminders:

• Ghrelin is investigational and not FDA-approved for any indication
• Long-term safety is not established; use beyond 12 weeks should be approached cautiously
• Injection site rotation, proper reconstitution, and refrigeration are essential
• Dosing on an empty stomach maximizes appetite-stimulating efficacy
• Individual response varies; monitor hunger, side effects, and relevant biomarkers regularly

Consult a qualified healthcare provider before initiating any ghrelin protocol, particularly if you have diabetes, obesity, hormonal dysregulation, or risk factors for tumor growth or metabolic dysfunction.